Kriya Therapeutics, Inc.
Kriya Therapeutics is a biopharmaceutical company developing gene therapies for chronic diseases, with $921M in funding and 199 employees. It has raised one of the largest funding totals among gene therapy startups, with a Series D in 2025.
The growth story
Kriya Therapeutics, Inc. grew from 96 to 199 employees between 2021 and 2026, raising $921M along the way, most recently a Series D in August 2025.
About
Kriya develops gene therapies targeting chronic conditions in ophthalmology, metabolic diseases, and neurology. Biopharma firms and healthcare providers are the likely buyers for its treatments aimed at large patient populations.
The company has scaled rapidly since its 2019 founding, reaching nearly 200 employees. Its $921M funding haul is notable for a preclinical-stage biotech, with backers including Foresite Capital and Dexcel Pharma.
Founders and leadership
Research is the largest function with 36 employees, reflecting the company's focus on drug development. Leadership is split between operations in North Carolina's Research Triangle and Palo Alto.
The Kriya Therapeutics, Inc. org chart
Shankar Ramaswamy, M.D. (Co-Founder and Chief Executive Officer) leads 58 mapped leaders with 7 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Research 49 (-25% YoY), Operations 25 (+19% YoY), Quality Assurance 22 (+5% YoY), Information Technology 17 (+6% YoY), Engineering 17 (+13% YoY), Business Development 13 (-28% YoY).
Talent flow
Nearly 20% of profiled employees came from Biogen, with others from Pfizer and Novartis. Alumni frequently move to other biotechs like FUJIFILM Biotechnologies and Avalyn Pharma.
Most common previous employers of Kriya Therapeutics, Inc. staff: Biogen (31), North Carolina State University (19), Pfizer (15), Novartis (13), KBI Biopharma (10), The University of North Carolina at Chapel Hill (10). Former Kriya Therapeutics, Inc. employees most often moved to FUJIFILM Biotechnologies (5), Biogen (4), Avalyn Pharma (3), KBI Biopharma (3), Noema Pharma (3), AskBio (3).
Alumni worth knowing
The Kriya Therapeutics, Inc. mafia
Five alumni-founded companies include Noema Pharma (35 staff) and Ambros Therapeutics (32 staff), showing strong entrepreneurial spillover from Kriya's gene therapy focus.
5Ilise Lombardo, was President, Therapeutic Division until 2023Kunal Kishnani, was President of Rare Diseases until 2023Theresa H., was Chief Medical Officer and President, Kriya Ophthalmology until 2023Dylan Clark, was Associate Director, Operations Technology until 2021Dana Johnson, was Chief Legal Officer & Corporate Secretary until 2024Hiring now
What this company is made of
Most common skills at Kriya Therapeutics, Inc.: Biotechnology (57), Microsoft Office (54), Cell Culture (51), Leadership (48), Research Skills (48), Good Manufacturing Practice (GMP) (47), Project Management (44), Microsoft Excel (44).
Where the team actually sits
Kriya Therapeutics, Inc. people are concentrated in North Carolina, United States (90), Raleigh-Durham-Chapel Hill Area (51), California, United States (7), United States (7).
What employees say
- Compensation
- 4.30 / 5
- Career opportunities
- 3.90 / 5
- Senior management
- 2.90 / 5
- Work-life balance
- 4.20 / 5
Frequently asked
Kriya Therapeutics, Inc. has 199 employees as of September 2026.
Kriya Therapeutics, Inc. has raised $921M in total, most recently a Series D round in August 2025.
Kriya Therapeutics, Inc. was founded in 2019 by J Fraser Wright, Roger Jeffs, Shankar Ramaswamy, M.D..
Shankar Ramaswamy, M.D. (Co-Founder and Chief Executive Officer) sits at the top of Kriya Therapeutics, Inc.'s reporting structure, with 7 direct reports.
The most common previous employers of current Kriya Therapeutics, Inc. staff are Biogen (31 people), North Carolina State University (19 people), Pfizer (15 people).
Former Kriya Therapeutics, Inc. employees most often move to FUJIFILM Biotechnologies (5), Biogen (4), Avalyn Pharma (3).
At least 5 companies have a founder who previously worked at Kriya Therapeutics, Inc., including Noema Pharma, Ambros Therapeutics, Eyexora.
The most common skills among Kriya Therapeutics, Inc. staff are Biotechnology, Microsoft Office, Cell Culture, Leadership, Research Skills.
Kriya Therapeutics, Inc. staff are concentrated in North Carolina, United States (90), Raleigh-Durham-Chapel Hill Area (51), California, United States (7).
Kriya Therapeutics, Inc. has about 49 people in Research, down 25% over the past year, as of September 2026.
Kriya Therapeutics, Inc. has about 25 people in Operations, up 19% over the past year, as of September 2026.
Computed from 181 current and 174 former Kriya Therapeutics, Inc. profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.